30th March 2020

 Newsletter March 2020


New Publication: The Lancet Haematology Journal

The results of DEEP-2 study have been accepted for publication on The Lancet Haematology Journal. DEEP-2 is one of three studies foreseen in the DEEP (DEferiprone Evaluation in Paediatrics) project, a 6-year European Project (FP7) coordinated by CVBF. 

Read more

New Publication on IntechOpen Journal

Are you interested in paediatric drug discovery? You might find of interest the chapter “Challenges and New Frontiers in the Paediatric Drug Discovery and Development” which was included in the book “Drug Discovery and Development – New Advances” published by IntechOpen Journal.

Read more

Share4Brain project was kicked off: sharing good practises on brain research

On 16th and 17th March, 2020 the new Erasmus+ project Sharing Good practices for Brain Education in Europe (Share4Brain) was kicked off. In light of the COVID-19 epidemic, the kick-off meeting (KoM) was held by teleconference, in the context of the International Brain Awareness Week (BAW2020) and was aimed to discuss the future activities and the strategies to implement the two-years project.

Read more

A new project for CVBF: SINERGY

Fondazione Città della Speranza-Onlus awarded the SYNERGY project, started in 2019 with the aim to fill in the pre-clinical gaps required to allow the clinical application of extracellular vescicles (EVs) for the treatment of Bronchopulmonary dysplasia (BPD).

Read more

CVBF is involved in the multinational clinical study SAIL

SAIL is an observational study to assess the effectiveness, safety profile and real-life prescribing and utilization patterns of tildrakizumab in patients with moderate to severe plaque psoriasis in routine clinical practice.

Read more

HEPATOMICS: CVBF will contribute to the new project selected by the Cypriot Research Promotion Foundation

HEPATOMICS project aims primarily to identify potential non-invasive, novel serum diagnostic biomarkers for different stages of liver disease (fibrosis and cirrhosis) in β-thalassaemia patients using combined data from proteomics, metabolomics and transcriptomics.

Read more

Italian Web Portal on Rare Diseases

The Italian Ministry of Health presented the new website www.malattierare.gov.it dedicated to rare diseases to collect all the reference points on the Italian territory for rare patients. The new interinstitutional portal on rare diseases is dedicated to patients, their families and all operators of the national health system involved in the world of these pathologies.

Read more

EMA public engagement highlights: an overview on activities in 2019

On March 2020, the European Medicines Agency released its annual overview of the involvement of patients and healthcare professionals in the work of the Agency. The report underlined a high percentage (90%) of cases, in which coordinators of scientific advice procedures considered patient involvement as a key action in their decision-making process.

Read more

COVID-19: what is the current situation of the International Authorities

Which measures FDA and EMA are adopting for facing the COVID-19 emergency? What does it imply into normal clinical research activities? Have a look at the current global situation.

Read more

ER ICU. COVID-19 Dataset

Since the terrible stress upon hospitals and ICUs is one of the greatest challenges the disease created, the State of Israel is establishing a central data center, where medical electronic records (ER) of the COVID-19 patients, and particularly the Intensive Care Units (ICU) ER, shall be gathered.

Read more


April 2020, 2-3

EPTRI Virtual Meeting
Due to the situation related to the coronavirus infection and the declaration of the pandemic status by the WHO, the EPTRI Open Meeting will be performed remotely, to guarantee the safely participation of everybody and the contribution to this crucial meeting.

Read more

April 2020, 28

EUCROF Webinar
The EUCROF Events&Training Working Group, which Chair is our CEO Dr Donato Bonifazi, presents the webinar “Traceability in Clinical Trials: Challenges of the new EU TMF/eTMF Guideline” that will be held on 28 April 2020 (from 10:00 to 11:30 CET).

Read more




Consorzio per Valutazioni Biologiche e Farmacologiche

I-70122 BARI Via Nicolò Putignani 178

You received this email because you are involved in the CVBF ACTIVITIES.

unsubscribe from this list    update subscription preferences

Newsletter service powered by Consorzio per Valutazioni Biologiche e Farmacologiche – [email protected]


About the Author: Flogert Dollani


By Published On: March 30th, 2020Categories: Newsletter0 Comments